GlassScriptPhysician profile
Matina Goodwin
NPI 1275676736
$974.90
in general payments reported to CMS, 2019-2025
16 companies · $117 in 2025
The $117 reported for 2025 was more than what a typical Pediatrics (Nurse Practitioner) provider received nationally (typical 2025 total: $93.49).
See the full distribution for Pediatrics (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $53.64 · 2022: $177 · 2023: $360 · 2024: $267 · 2025: $117.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $744.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $743.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $232.43 | 2022-2024 | Azstarys |
| Ironshore Pharmaceuticals INC. | $209.09 | 2022-2024 | Jornay Pm |
| Merck Sharp & Dohme LLC | $137.27 | 2021-2025 | Gardasil 9, Vaxelis, Vaxneuvance |
| Neos Therapeutics, LP | $85.26 | 2022-2024 | Adzenys Xr-Odt, Cotempla Xr-Odt |
| Takeda Pharmaceuticals U.S.A., INC. | $48.65 | 2025 | Elaprase |
| Kaleo, INC. | $44.03 | 2021-2024 | Auvi-Q |
| Cranial Technologies, INC | $38.58 | 2023 | Doc Band |
| Pfizer INC. | $34.73 | 2023-2024 | |
| Tris Pharma INC | $25.12 | 2022-2024 | Dyanavel Xr |
| Biogen, INC. | $24.20 | 2024 | Spinraza |
| Sanofi Pasteur INC. | $19.78 | 2024 | |
| Lnhc, INC | $18.93 | 2025 | Zelsuvmi |
| Collegium Pharmaceutical, INC. | $17.16 | 2025 | Jornay Pm |
| Seqirus USA INC | $15.94 | 2025 | Flucelvax |
| Adlon Therapeutics L.P. | $12.73 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $11.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matina Goodwin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.